10x Genomics, Inc. · NASDAQ:TXG
Taich Adam sold 46,388 10x Genomics, Inc. shares (Form 4)
Traded Sep 9, 2026 · Filed Sep 11, 2026
On Sep 9, 2026, Taich Adam (Chief Financial Officer) sold 46,388 10x Genomics, Inc. shares at an average US$64.58 for US$3M under a trading plan, leaving 316,344 shares. Filed Sep 11, 2026 (Form 4).
- Sold
- 46,388 shares
- Price
- US$64.58 average (US$63.68 to US$65.26)
- Value
- US$3M
- Holding after
- 316,344 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Class A Common Stock | Sale | 1,206 | US$63.68 | 361,526 | Direct |
| Sep 9, 2026 | Class A Common Stock | Sale | 31,428 | US$64.31 | 330,098 | Direct |
| Sep 9, 2026 | Class A Common Stock | Sale | 13,754 | US$65.26 | 316,344 | Direct |
Source
Related
- 10x Genomics, Inc.
- Taich Adam
- 10x Genomics, Inc. shareholders
- Form 4 · Taich Adam · Aug 26, 2026
- Form 4 · Taich Adam · May 27, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Stuelpnagel John R · Sep 8, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Sep 8, 2026